跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2611.13562 · v1

An evidence-traceable benchmark of clinical reasoning in large language models

首次提交 2026-11-10 12:28
版本更新 2026-11-10 12:28
雷达观测 2026-11-11 13:08
arXiv ↗PDF ↗

摘要

Benchmark scores for medical large language models (LLMs) are difficult to interpret when scoring criteria cannot be traced to clinical evidence. Here we developed Med Evidence Bench (MEB; https://www.medevidencebench.org.cn/), comprising 1,536 physician-constructed items across three levels: guideline knowledge, standardized clinical scenarios and real-world laboratory scenarios. Each criterion stating a medical claim is linked to a versioned source-text span. Across ten LLMs, the Evidence Trace Score (ETS) was 0.975-0.997 for guideline knowledge, 0.292-0.658 for standardized scenarios and 0.182-0.447 for real-world scenarios, and rankings varied across levels. For real-world scenarios, scores for identifying clinical information (mean, 0.770) exceeded those for matching evidence (0.165) or formulating recommendations (0.160). On 1,296 criterion-level judgments, automated grading agreed with the majority vote of three physicians (macro-F1, 0.930; 95% confidence interval, 0.915-0.945), although agreement was lower for evidence application. These findings from Chinese-language materials indicate that guideline recall does not ensure patient-specific evidence use and do not establish clinical effectiveness.

作者备注:25 pages, 8 figures, 4 tables. Zhiqun Zhao, Xiaodong Yang and Bruce Gu contributed equally. Corresponding authors: Zheng Wang, Haiquan Lu and Xiaoming Wu

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只观测到一个版本,无法比较变化。之后收录新版本时,会在这里对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v1 · 2026-11-10 12:28 · 最新观测版本

An evidence-traceable benchmark of clinical reasoning in large language models

Benchmark scores for medical large language models (LLMs) are difficult to interpret when scoring criteria cannot be traced to clinical evidence. Here we developed Med Evidence Bench (MEB; https://www.medevidencebench.org.cn/), comprising 1,536 physician-constructed items across three levels: guideline knowledge, standardized clinical scenarios and real-world laboratory scenarios. Each criterion stating a medical claim is linked to a versioned source-text span. Across ten LLMs, the Evidence Trace Score (ETS) was 0.975-0.997 for guideline knowledge, 0.292-0.658 for standardized scenarios and 0.182-0.447 for real-world scenarios, and rankings varied across levels. For real-world scenarios, scores for identifying clinical information (mean, 0.770) exceeded those for matching evidence (0.165) or formulating recommendations (0.160). On 1,296 criterion-level judgments, automated grading agreed with the majority vote of three physicians (macro-F1, 0.930; 95% confidence interval, 0.915-0.945), although agreement was lower for evidence application. These findings from Chinese-language materials indicate that guideline recall does not ensure patient-specific evidence use and do not establish clinical effectiveness.

查看此版本解读 →查看此版本原文 ↗